When Depression Has Not Responded to Standard Treatment
Depression can affect nearly every part of life: energy, sleep, motivation, appetite, concentration, relationships, work, and the ability to feel like yourself. For many people, treatment with medication, therapy, or lifestyle changes brings meaningful improvement. But for others, symptoms continue despite doing the work and trying the recommended steps.
That is where treatment-resistant depression becomes part of the conversation.
Treatment-resistant depression generally refers to depression that has not improved enough after standard treatment attempts. This does not mean you are beyond help. It means your care may need a more careful, more specialized evaluation.
At Parker Neuroscience, treatment-resistant depression is approached with diagnostic clarity, medical precision, and a safety-first interventional psychiatry model. The goal is not to simply add another prescription and hope for the best. The goal is to understand why standard care may not have been enough and determine what treatment pathway is clinically appropriate for you.
What Is Treatment-Resistant Depression?
Treatment-resistant depression is commonly used to describe depression that has not responded adequately to traditional treatment, often after multiple medication trials or other psychiatric interventions.
Patients with treatment-resistant depression may have tried:
- Antidepressant medications
- Medication dose changes
- Medication combinations
- Therapy or counseling
- Lifestyle changes
- Primary care treatment
- Psychiatric care
- Other mental health interventions
Some patients have tried two or more medications without meaningful relief. Others have had partial improvement but still feel stuck, emotionally flat, unable to function, or unable to maintain progress.
Treatment-resistant depression does not always mean treatment has “failed.” Sometimes it means the diagnosis needs to be revisited. Sometimes it means medication side effects, medical conditions, trauma history, sleep disruption, anxiety, PTSD, or bipolar depression may be complicating the picture.
That is why Parker Neuroscience begins with evaluation first.
If your medication history is complicated or you are concerned about too many prescriptions, Parker Neuroscience also offers primary care mental health medication support in Omaha.
Signs You May Need a More Advanced Depression Evaluation
You may benefit from a treatment-resistant depression consultation if depression continues to interfere with your life despite previous treatment.
Common signs include:
- You have tried multiple antidepressants without enough improvement
- Medication helped at first but stopped working over time
- Depression keeps returning despite treatment
- Side effects have made medications difficult to tolerate
- You feel emotionally numb, disconnected, or unable to function
- You struggle with low motivation, fatigue, or loss of interest
- Your depression overlaps with anxiety, PTSD, or trauma-related symptoms
- You are unsure whether your current diagnosis fully explains your symptoms
- You feel like treatment has become a cycle of “try another medication”
A consultation does not commit you to a specific treatment. It gives you a structured clinical starting point. Dr. Parker reviews your history, current symptoms, medications, medical risk factors, and prior treatment response to determine what options may be appropriate.
Treatment-Resistant Depression Care at Parker Neuroscience
Parker Neuroscience was built for adults who need more than routine medication changes. The practice offers advanced psychiatric care with a focus on safety, individualized treatment planning, and interventional options for eligible patients.
Treatment may include one or more of the following pathways.
IV Ketamine Therapy
IV ketamine therapy may be considered for eligible adults with treatment-resistant depression after clinical evaluation. At Parker Neuroscience, IV ketamine is administered in a private clinical environment with individualized protocols, continuous monitoring, and defined discharge standards.
IV ketamine is used off-label in psychiatric care. It is not FDA-approved for depression or other psychiatric disorders, so candidacy, safety screening, and informed clinical decision-making are essential.
Learn more about IV ketamine therapy in Omaha.
Spravato Treatment
Spravato, also known as esketamine, is an FDA-approved treatment option for eligible adults with treatment-resistant depression. It is administered as a nasal spray in a REMS-certified healthcare setting and requires monitoring after each session.
For some patients, Spravato may be a more insurance-eligible interventional option, depending on diagnosis, documentation, medical necessity, and insurance plan requirements.
Learn more about Spravato treatment in Omaha.
Mental Health Medication Support
For some patients, the next step is not immediately ketamine or Spravato. It may be diagnostic clarification, medication review, primary care medication support related to mental health needs, simplifying a complex medication regimen, or identifying factors that have been missed.
Parker Neuroscience focuses on reducing unnecessary polypharmacy when appropriate and creating a coherent treatment pathway rather than simply adding more prescriptions. Formal psychiatric medication management services are anticipated to begin in early 2027, and the practice is accepting interest from patients seeking a psychiatric medication provider.
Learn more about primary care mental health medication support in Omaha.
Why Diagnostic Clarity Matters
Treatment-resistant depression is not always straightforward. Symptoms that look like depression may overlap with anxiety disorders, PTSD, bipolar depression, substance use concerns, sleep disorders, medical conditions, hormonal factors, chronic pain, or medication side effects.
That complexity matters.
A treatment plan that does not account for the full clinical picture can lead to years of frustration. Patients may be told to keep trying medication after medication without anyone stepping back to ask whether the diagnosis, strategy, or care model needs to change.
At Parker Neuroscience, diagnostic clarity comes before intervention. Dr. Parker evaluates your psychiatric history, treatment response, medications, medical risks, and current symptoms before recommending a treatment path.
The goal is to avoid rushed care, unsafe assumptions, and one-size-fits-all protocols.
What to Expect During Your Consultation
Your first step is a consultation with Dr. Parker. This visit is designed to determine whether Parker Neuroscience is the right fit for your needs and which treatment pathway may be safest and most appropriate.
During the consultation, Dr. Parker may review:
- Your depression symptoms and how long they have been present
- Prior diagnoses
- Medication history
- Therapy history
- Past treatment response
- Side effects or medication tolerability concerns
- Medical history
- Psychiatric risk factors
- Substance use history
- Blood pressure and cardiovascular considerations
- Symptoms of PTSD, anxiety, mania, psychosis, or bipolar depression
- Current treatment goals
This process helps determine whether IV ketamine therapy, Spravato, primary care mental health medication support, care coordination, future formal psychiatric medication management, or another referral pathway is appropriate.
Why Patients Choose Parker Neuroscience for Depression Care
Patients seeking treatment-resistant depression care in Omaha are often tired of being told to “just try one more thing” without a clear plan. Parker Neuroscience offers a different kind of evaluation: structured, medically grounded, and focused on safety.
Interventional Psychiatry Focus
Parker Neuroscience specializes in advanced psychiatric treatment options, including IV ketamine therapy and Spravato, for eligible adults who have not found adequate relief through traditional care.
Evaluation Before Treatment
Treatment begins with a thorough review of your diagnosis, medication history, medical risks, and treatment goals. The goal is clinical appropriateness, not rushing into a procedure.
Individualized Treatment Planning
Depression is not treated as a generic checklist. Your treatment pathway is developed around your history, symptoms, prior response, and safety considerations.
Safety-First Care
Parker Neuroscience uses defined protocols, careful monitoring, and clear discharge standards for interventional treatments. If a treatment is not appropriate, you will be told directly.
Care That Can Coordinate With Your Existing Team
If you already work with a therapist, psychiatrist, primary care provider, or referring clinician, Parker Neuroscience can coordinate care when appropriate.
Important Crisis Note
Parker Neuroscience provides outpatient psychiatric care and interventional treatment evaluation. This page is not intended for emergency or crisis support.
If you are in immediate danger, feel unable to stay safe, or may harm yourself or someone else, call 911 or go to the nearest emergency department. If you need immediate emotional support, call or text 988 to reach the Suicide & Crisis Lifeline.
Insurance and Treatment Access
Treatment access depends on the type of care recommended.
Spravato is FDA-approved and may be insurance-eligible for patients who meet plan requirements, documentation standards, and medical necessity criteria. Parker Neuroscience can help with prior authorization and REMS-related steps when appropriate.
IV ketamine therapy is not currently covered by most commercial insurance plans and is offered on a transparent private-pay basis. Veterans enrolled in the VA Community Care Network may qualify for VA-covered ketamine therapy depending on eligibility and authorization.
Parker Neuroscience currently accepts patients for primary care medication support related to mental health needs. Formal psychiatric medication management services are anticipated to begin in early 2027, and insurance participation, benefits, service availability, and costs should be confirmed directly during the consultation process.
Depression, PTSD, and Anxiety Often Overlap
Many patients with treatment-resistant depression are not dealing with depression alone. PTSD, chronic stress, panic, generalized anxiety, trauma history, grief, burnout, and medical stress can all shape how depression presents and how it responds to treatment.
If depression exists alongside trauma or anxiety, the treatment plan may need to address more than mood symptoms. It may require coordination with therapy, medication review, interventional treatment, or a broader psychiatric strategy.
Parker Neuroscience evaluates the whole clinical picture so treatment is not built around one symptom in isolation.
If trauma symptoms are part of your history, learn more about PTSD treatment options in Omaha. If persistent worry, panic, or nervous system overactivation are major concerns, visit anxiety treatment in Omaha.
Treatment-Resistant Depression FAQs
What does treatment-resistant depression mean?
Treatment-resistant depression generally refers to depression that has not improved enough after standard treatment attempts, such as antidepressant medication, therapy, or other psychiatric care. A consultation can help determine whether the issue is treatment resistance, diagnostic complexity, medication tolerability, or another factor.
How many medications do I need to try before depression is considered treatment-resistant?
There is not one universal definition used in every setting, but treatment-resistant depression is often discussed when a person has not had adequate improvement after multiple appropriate treatment attempts. Dr. Parker reviews your specific medication history, dose history, response, side effects, and diagnosis during the evaluation.
Does Parker Neuroscience treat treatment-resistant depression in Omaha?
Yes. Parker Neuroscience provides advanced treatment-resistant depression care in Omaha for adults, including evaluation for IV ketamine therapy, Spravato, primary care mental health medication support, and coordinated treatment planning.
Is ketamine used for treatment-resistant depression?
IV ketamine may be considered as an off-label interventional treatment option for eligible adults after clinical evaluation. Ketamine is not FDA-approved for psychiatric disorders, so safety screening, monitoring, and appropriate medical oversight are essential.
Is Spravato FDA-approved for treatment-resistant depression?
Yes. Spravato, also known as esketamine, is FDA-approved for treatment-resistant depression in adults. It must be administered in a certified healthcare setting under REMS requirements and requires monitoring after each session.
How do I know whether IV ketamine or Spravato is better for me?
The right option depends on your diagnosis, treatment history, medical risk factors, insurance considerations, medication history, and clinical goals. Parker Neuroscience evaluates these factors during your consultation before recommending a treatment pathway.
Can medication review or mental health medication support still help if I have treatment-resistant depression?
Yes, in some cases. Treatment-resistant depression does not always mean medications are useless. It may mean the current medication strategy needs to be reviewed, simplified, adjusted, or better aligned with the correct diagnosis.
What if I have depression and anxiety?
Depression and anxiety commonly overlap. Parker Neuroscience evaluates the full clinical picture rather than treating symptoms in isolation. Your care plan may include medication review, interventional treatment evaluation, therapy coordination, or another individualized approach.
What if I have depression and PTSD?
Depression and PTSD can occur together, especially when trauma affects sleep, mood, emotional regulation, and daily functioning. If PTSD symptoms are part of your history, Dr. Parker can consider that as part of the evaluation and treatment planning process.
Do I need a referral?
Parker Neuroscience welcomes self-referrals and provider referrals. If you already work with a therapist, psychiatrist, primary care provider, or other clinician, Parker Neuroscience can coordinate care when appropriate.
Start With a Consultation
Ready to talk through your options?
Parker Neuroscience welcomes self-referrals, provider referrals, and general questions from adults exploring advanced psychiatric care in Omaha and throughout Nebraska.
Please do not include medical history, symptoms, medication details, or urgent health concerns in this form.